Virology Expertise

In the intricate realm of virology, where viruses pose a constant threat to human health, preclinical research and testing stand as a beacon of hope. At Southern Research, we are committed to providing comprehensive preclinical virology services, empowering researchers to unravel the complexities of viral infections and pave the way for groundbreaking antiviral therapies.


Navigate the Complexities of Preclinical Virology Research and Testing with Expert Guidance

Our team of seasoned virologists, immunologists, and cellular biologists brings decades of experience to the table, possessing an in-depth understanding of viral pathogenesis, replication mechanisms, and antiviral drug discovery and development. We are well-versed in a wide range of in vitro and in vivo virology assays, capable of evaluating the efficacy, safety, and pharmacokinetic properties of potential antiviral compounds or therapies.

We offer a comprehensive suite of preclinical virology services tailored to meet the diverse needs of our clients, encompassing every stage of the research process:

Target Identification and Validation: We help you identify and validate novel antiviral targets, laying the foundation for effective drug discovery efforts.

Antiviral Compound Screening and Optimization: We employ a range of in vitro screening assays to identify promising antiviral candidates and optimize their potency and selectivity.

Efficacy and Safety Testing in Animal Models: We conduct rigorous efficacy and safety testing in animal models to assess the therapeutic potential of antiviral compounds while ensuring their safety profile.

Pharmacokinetic and Pharmacodynamic (PK/PD) Studies: We determine the absorption, distribution, metabolism, and excretion (ADME) properties of antiviral compounds, providing valuable insights into their pharmacokinetic profiles.

Regulatory Support and IND Preparation: We guide you through the intricate regulatory landscape, ensuring compliance with FDA guidelines and facilitating the preparation of Investigational New Drug (IND) applications.

Southern Research has a strong track record of translating our research findings into clinical practice. For example, Southern Research has played a key role in the development of several successful antiviral drugs, including:

Sofosbuvir: A first-in-class drug that revolutionized the treatment of hepatitis C virus (HCV) infection.
Remdesivir: A broad-spectrum antiviral drug that has been shown to be effective against a variety of viruses, including SARS-CoV-2 (COVID-19).

Southern Research is also at the forefront of research on emerging viral diseases and have BSL-2/3 lab capabilities. We are working to develop new diagnostic tools, treatments, and vaccines for these and other emerging threats.

The Power of Collaboration

Amplifying Your Research Impact

Partnering with Southern Research provides you with access to a wealth of expertise, resources, and infrastructure, enabling you to focus on your core competencies while we handle the complexities of preclinical virology research and testing. This strategic alliance empowers you to:

  1. Accelerate your research timelines
  2. Enhance the efficiency and productivity of your research efforts
  3. Optimize resource allocation and cost-effectiveness
  4. Ensure adherence to stringent regulatory standards, including GLP CGLP
  5. Mitigate the risk of project delays or failures

Contact Us Today

At Southern Research, we are passionate about unlocking the secrets of viruses and contributing to the development of life-saving medical countermeasures. We are your trusted partner in preclinical infectious disease research and testing, providing you with the expertise and support you need to make a lasting impact on global health. Reach out to us to learn more today.

Basic Template Image